Pfizer Inc on Friday said it would raise US prices on 41 drugs in January, reversing a price freeze implemented over the summer in the face of criticism by US President Donald Trump.
The increases, which are to take effect on Jan. 15, apply to just 10 percent of its entire drug portfolio and would in many cases be offset by discounts to patients provided through insurance companies and drug benefits, Pfizer said.
Trump said the company “should be ashamed” after it raised prices in July, after which Pfizer reversed its increases, although a spokesperson at the time said the freeze would remain in place only until the end of the year.
A Pfizer spokeswoman on Friday declined to specify which drugs would be subject to the 5 percent price hike.
The Wall Street Journal in July reported that those to go up in price included a lung cancer treatment, blood pressure pills and the pain medication Lyrica.
Three drugs are to see prices rise 3 percent, while one would jump 9 percent “due to the completion of two extensive development programs that have led to the recent [US Food and Drug Administration] FDA approvals of two new medical uses that meet unmet patient needs.”
“Given the higher rebates and discounts, we expect that the healthcare system will share those benefits with patients so they do not experience higher costs for their medicines,” the company said.
The increases are not expected to affect revenue next year, while prices subtracted 1 percent from revenue this year, Pfizer said.
While Pfizer regularly takes price increases throughout the year, these planned increases are fewer in number than it usually takes.
However, US officials criticized the announcement.
The move illustrates the “perverse incentives of America’s drug pricing system,” US Health and Human Services spokesman Alex Azar said.
The company’s share price closed with a gain of 0.7 percent to US$43.51 in New York trading on Friday.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last